Microsoft Word 88 Hemofiliya

55 

17.

 

Evatt BL, Austin H, Leon G, Ruiz-Sáez A, de Bosch N. Haemophilia 

therapy: assessing the cumulative risk of HIV exposure by 

cryoprecipitate. [Electronic resource]. Haemophilia 1999; 5(5):295-

300. - Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/10583509?dopt=Abstract (20.10.2014) 

18.

 

Evatt BL, Black C, Batorova A, Street A, Srivastava A. Comprehensive 

care for haemophilia around the world. [Electronic resource]. 

Haemophilia 2004; 10 (Suppl 4):9-13. - Available at:  

http://www.ncbi.nlm.nih.gov/pubmed/15479365?dopt=Abstract (20.10.2014) 

19.

 

Eyster ME, Asaad SM, Gold BD, Cohn SE, Goedert JJ; Second 

Multicenter Hemophilia Study Group. Upper gastrointestinal bleeding 

in haemophiliacs: incidence and relation to use of non-steroidal anti-

inflammatory drugs. [Electronic resource]. Haemophilia  2007; 

13(3):279-86. - Available at:  

http://www.ncbi.nlm.nih.gov/pubmed/17498077?dopt=Abstract (20.10.2014) 

20.

 

Farrugia A. Guide for the assessment of clotting factor concentrates, 

2nd ed. [Electronic resource]. Montreal: World Federation of 

Hemophilia, 2008.- Available at: 

http://www1.wfh.org/publication/files/pdf-1271.pdf (20.10.2014) 

21.

 

Franchini M, Zaffanello M, Lippi G. The use of desmopressin in mild 

hemophilia A. [Electronic resource]. Blood Coagul Fibrinolysis 2010; 

21(7):615-9. - Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/20829683?dopt=Abstract  (20.10.2014) 

22.

 

Franchini M, Rossetti G, Tagliaferri A, et al. Dental procedures in adult 

patients with hereditary bleeding disorders: 10 years experience in 

three Italian Hemophilia Centers. [Electronic resource]. Haemophilia 

2005; 11:504-9. - Available at:  

http://www.ncbi.nlm.nih.gov/pubmed/16128895?dopt=Abstract(20.10.2014) 

23.

 

Franchini M, Mengoli C, Veneri D, Mazzi R, Lippi G, Cruciani M. 

Treatment of chronic hepatitis C in haemophilic patients with 

interferon and ribavirin: a meta-analysis. [Electronic resource]. J 

Antimicrob Chemother 2008; 61(6):1191-200. - Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/18356154?dopt=Abstract  (20.10.2014) 

24.

 

Frachon X, Pommereuil M, Berthier AM, et al. Management options 

for dental extraction in hemophiliacs: a study of 55 extractions (2000-

2002). [Electronic resource]. Oral Surg Oral Med Oral Pathol Oral 

Radiol Endod 2005; 99(3):270-5. - Available at:  

 

 

 

 

 

 

Klinik protokol Az

ərbaycan Respublikas

ı S

əhiyy

ə Nazirliyinin 

İctimai S

əhi

yy

ə v

ə 

İslahatlar M

ərk

əzind

ə haz

ırlanm

ış

dı

r. 

---

56 

http://www.ncbi.nlm.nih.gov/pubmed/15716831?dopt=Abstract  (20.10.2014) 

25.

 

Gomis M, Querol F, Gallach JE, Gonzalez LM, Aznar JA. Exercise and 

sport in the treatment of haemophilic patients: a systematic review. 

[Electronic resource]. Haemophilia 2009; 15(1):43-54.- Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/18721151?dopt=Abstract  (20.10.2014) 

26.

 

Giangrande PL, Wilde JT, Madan B, et al. Consensus protocol for the 

use of recombinant activated factor VII in elective orthopaedic surgery 

in haemophilic patients with inhibitors. [Electronic resource]. 

Haemophilia 2009; 15(2):501-8. - Available at:  

http://www.ncbi.nlm.nih.gov/pubmed/19187194?dopt=Abstract  (20.10.2014) 

27.

 

Gringeri A, Lundin B, Mackensen SV, et al. A randomized clinical trial 

of prophylaxis in children with hemophilia A (the ESPRIT Study). 

[Electronic resource]. J Thromb Haemost 2011; 9(4):700-10. - 

Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/21255253?dopt=Abstract  (20.10.2014) 

28.

 

Guidelines for the management of hemophilia. [Electronic resource]. 

2nd edition. 2012.- Available at: www.WFH.org (20.10.2014) 

29.

 

Hartwell D, Jones J, Baxter L, Shepherd J. Peginterferon alfa and 

ribavirin for chronic hepatitis C in patients eligible for shortened 

treatment, re-treatment or in HCV/HIV co-infection: a systematic 

review and economic evaluation. [Electronic resource]. Health Technol 

Assess 2011 Apr; 15(17):i-xii, 1-210.  - Available  at:  

http://www.ncbi.nlm.nih.gov/pubmed/21473834?dopt=Abstract (20.10.2014) 

30.

 

Hay CR, Brown S, Collins PW, Keeling DM, Liesner R. The diagnosis 

and management of factor VIII and IX inhibitors: a guideline from the 

United Kingdom Haemophilia Centre Doctors Organisation. [Electronic 

resource]. Br J Haematol 2006; 133:591-605. - Available at:  

http://www.ncbi.nlm.nih.gov/pubmed/16704433?dopt=Abstract  (20.10.2014) 

31.

 

Hermans C, de Moerloose P, Fischer K, Holstein K, Klamroth R, 

Lambert T, et al; European Haemophilia Therapy Standardisation 

Board. Management of acute haemarthrosis in haemophilia A without 

inhibitors: literature review, European survey and recommendations. 

[Electronic resource]. Haemophilia 2011; 17(3):383-92. - Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/21323794?dopt=Abstract  (20.10.2014) 

32.

 

Hermans C, Altisent C, Batorova A, et al.; European Haemophilia 

Therapy Standardisation Board. Replacement therapy for invasive 

procedures in patients with haemophilia: literature review, European 

 

 

 

 

 

 

Klinik protokol Az

ərbaycan Respublikas

ı S

əhiyy

ə Nazirliyinin 

İctimai S

əhi

yy

ə v

ə 

İslahatlar M

ərk

əzind

ə haz

ırlanm

ış

dı

r. 

---